Magnetic brain stimulation for treatment-resistant depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether repeated magnetic brain stimulation (rTMS) can help people with depression that hasn't improved with standard treatment. Participants must be taking a specific antidepressant and be right-handed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have been diagnosed with depression that has not responded to usual treatments
- You are currently taking venlafaxine at a dose of 150 mg per day
- You are right-handed
- You are not pregnant or breastfeeding
- You have no history of seizures, migraines, or head trauma, and no metal implants in your head or heart
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different ways of delivering transcranial magnetic stimulation (TMS) to see which works better for people with depression that hasn't improved with medication.
This study tests a type of brain stimulation called rTMS that is guided by brain scans to treat depression. It may help people who haven't gotten better with at least two past treatments.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
This study compares two fast types of brain stimulation (called accelerated theta burst stimulation) to see which works better for people whose depression hasn't improved with standard antidepressants. It's designed for people with treatment-resistant depression who are already on a stable antidepressant.
This trial is testing a type of brain stimulation therapy called theta-burst rTMS to see if it helps with depression that hasn't improved with standard treatments. It also uses brain scans to predict who might respond best.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.